[Federal Register Volume 91, Number 83 (Thursday, April 30, 2026)]
[Notices]
[Pages 23314-23315]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2026-08415]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-608; NRC-2019-0029]
In the Matter of SHINE Technologies, LLC; SHINE Medical Isotope
Production Facility; Direct and Indirect Transfers of License
AGENCY: Nuclear Regulatory Commission.
ACTION: Order; issuance.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing an
order approving the license transfer application filed by SHINE
Technologies, LLC, dated February 4, 2026, as supplemented on April 13,
2026. Specifically, the order approves the direct transfer of
Construction Permit No. CPMIF-001 for the SHINE Medical Isotope
Production Facility from SHINE Technologies, LLC to SHINE Chrysalis,
LLC and a conforming license amendment. The order also approves the
indirect transfer of control of the construction permit as a result of
the establishment of SHINE Chrysalis Holdings, LLC as the direct parent
company of SHINE Chrysalis, LLC. SHINE Chrysalis Holdings, LLC is a
wholly owned subsidiary of Illuminated Holdings, Inc., the current
parent company of SHINE Technologies, LLC.
DATES: The order was issued on April 22, 2026, and is effective for one
year.
ADDRESSES: Please refer to Docket ID NRC-2019-0029 when contacting the
NRC about the availability of information regarding this document. You
may obtain publicly available information related to this document
using any of the following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2019-0029. Address
questions about Docket IDs in Regulations.gov to Bridget Curran;
telephone: 301-415-1003; email: [email protected]. For technical
questions, contact the individual listed in the For Further Information
Contact section of this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin ADAMS Public Search.''
For problems with ADAMS, please contact the NRC's Public Document Room
(PDR) reference staff at 1-800-397-4209, at 301-415-4737, or by email
to [email protected]. The ADAMS accession number for each document
referenced (if it is available in ADAMS) is provided the first time
that it is mentioned in this document.
NRC's PDR: The PDR, where you may examine and order copies
of publicly available documents, is open by appointment. To make an
appointment to visit the PDR, please send an email to
[email protected] or call 1-800-397-4209 or 301-415-4737, between 8
a.m. and 4 p.m. eastern time (ET), Monday through Friday, except
Federal holidays.
FOR FURTHER INFORMATION CONTACT: Michael Balazik, Office of Nuclear
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2856; email: [email protected].
SUPPLEMENTARY INFORMATION: The text of the Order is attached.
Dated: April 28, 2026.
For the Nuclear Regulatory Commission.
Michael Balazik,
Senior Project Manager, Non-Power Production and Utilization Facility
Licensing Branch, Division of Advanced Reactors and Non-Power
Production and Utilization Facilities, Office of Nuclear Reactor
Regulation.
Attachment--Order Approving Direct and Indirect Transfers of License
and Conforming Amendment
UNITED STATES OF AMERICA
NUCLEAR REGULATORY COMMISSION
In the Matter of: SHINE Technologies, LLC, Docket No. 50-608, SHINE
Medical Isotope Production Facility, Construction Permit No. CPMIF-001.
ORDER APPROVING DIRECT AND INDIRECT TRANSFERS OF LICENSE AND CONFORMING
AMENDMENT
I
SHINE Technologies, LLC (SHINE Technologies) is the holder of
Construction Permit (CP) No. CPMIF-001, which the U.S. Nuclear
Regulatory Commission (NRC, the Commission) issued on February 29,
2016, for the construction of the SHINE Medical Isotope Production
Facility (SHINE facility) in Rock County, Wisconsin. SHINE Technologies
is a wholly owned subsidiary of Illuminated Holdings, Inc.
(Illuminated). The SHINE facility is currently being constructed.
II
Pursuant to section 184, ``Inalienability of Licenses,'' of the
Atomic Energy Act of 1954, as amended (AEA), and title 10 of the Code
of Federal Regulations (10 CFR) section 50.80, ``Transfer of
licenses,'' by application dated February 4, 2026 (Agencywide Documents
Access and Management System (ADAMS) Package Accession No.
ML26035A418), as supplemented on April 13, 2026 (ML26103A270), SHINE
Technologies requested that the NRC consent to the direct transfer and
indirect transfer of control of CP No. CPMIF-001. SHINE Technologies
stated that these transfers were necessitated by an advanced loan
application with the U.S. Department of Energy (DOE) to provide funds
for the completion of the construction of the SHINE facility. To
facilitate the loan application and DOE loan, Illuminated would form a
new wholly owned subsidiary, SHINE Chrysalis, LLC (SHINE Chrysalis).
The direct transfer would occur when Illuminated transfers the CP and
related assets from SHINE Technologies to SHINE Chrysalis. The indirect
transfer of control would occur when, concurrent with the direct
transfer, SHINE Chrysalis Holdings, LLC (Chrysalis Holdings), a direct
subsidiary of Illuminated, becomes the direct parent company of SHINE
Chrysalis. Pursuant to 10 CFR 50.90, ``Application for amendment of
license, construction permit, or early site permit,'' SHINE
Technologies also requested that the NRC approve a conforming
administrative amendment to the CP to reflect the proposed direct
transfer.
On March 6, 2026, the NRC published a notice of consideration of
approval of the license transfer application in the Federal Register
(FR) (91 FR 11089). This notice provided an opportunity to comment,
request a hearing, and petition for leave to intervene on the license
transfer application. The NRC received one public comment (ML26099A079)
in support of approving the license transfer. The NRC did not receive
any hearing requests in response to the notice.
Pursuant to 10 CFR 50.80, no license for a production or
utilization facility, or any right thereunder, shall be transferred,
either voluntarily or involuntarily, directly or indirectly, through
transfer of control of the license to any person, unless the Commission
gives its consent in writing. Upon review of the information in the
license transfer application and other information before the
Commission, and
[[Page 23315]]
relying upon the representations contained in the application, the NRC
staff has determined that SHINE Chrysalis is qualified to be the holder
of the license and Chrysalis Holdings is qualified to be the indirect
holder of the license and that the transfers of the license, as
described in the application, are otherwise consistent with applicable
provisions of law, regulations, and orders issued by the Commission
pursuant thereto.
Upon review of the request in the license transfer application for
approval of a conforming administrative amendment to the license to
reflect the direct transfer, the NRC staff has determined that: (1) the
application for amendment complies with the standards and requirements
of the AEA and the Commission's rules and regulations set forth in 10
CFR Chapter I, (2) the facility will be constructed in conformity with
the application, the provisions of the AEA, and the rules and
regulations of the Commission, (3) there is reasonable assurance that
the activities authorized by the amendment can be conducted without
endangering the health and safety of the public and that such
activities will be conducted in compliance with the Commission's
regulations, (4) the issuance of the amendment will not be inimical to
the common defense and security or to the health and safety of the
public, and (5) the issuance of the amendment is in accordance with 10
CFR part 51, ``Environmental Protection Regulations for Domestic
Licensing and Related Regulatory Functions,'' of the Commission's
regulations and all applicable requirements have been satisfied.
The findings set forth above are supported by an NRC staff safety
evaluation dated the same date as this order, a public version of which
is available at ADAMS Accession No. ML26090A297.
III
Accordingly, pursuant to Sections 161b, 161i, and 184 of the AEA,
Title 42 of the United States Code Sections 2201(b), 2201(i), and 2234,
and 10 CFR 50.80 and 10 CFR 50.90, It is hereby ordered that the
license transfer application, as described herein, is approved.
It is further ordered that SHINE Technologies shall, at least 5
business days before the planned consummation of the license transfer
actions, inform the Director of the Office of Nuclear Reactor
Regulation in writing of the planned consummation date. Should the
proposed transfers not be completed within 1 year of the date of this
order, this order shall become null and void; provided, however, that
upon written application to the Director of the Office of Nuclear
Reactor Regulation and for good cause shown, such date may be extended
by order.
It is further ordered that consistent with 10 CFR 2.1315(b), the
license amendment that makes changes, as indicated in Enclosure 2 to
the letter forwarding this order, to reflect the subject direct license
transfer is approved. The amendment shall be issued and made effective
when the proposed license transfer actions are completed.
This order is effective upon issuance.
For further details with respect to this order, see the license
transfer application dated February 4, 2026 (ML26035A418), as
supplemented on April 13, 2026 (ML26103A270), and the associated NRC
staff safety evaluation dated the same date as this order. Publicly
available documents created or received at the NRC are accessible
electronically through ADAMS in the NRC Public Documents collection at
https://www.nrc.gov/reading-rm/adams.html. Persons who do not have
access to ADAMS or who encounter problems in accessing the documents
located in ADAMS, should contact the NRC Public Document Room reference
staff at 1-800-397-4209, at 301-415-4737, or by email to
[email protected].
Dated: April 22, 2026
For the Nuclear Regulatory Commission.
Jeremy Groom,
Acting Director, Office of Nuclear Reactor Regulation
[FR Doc. 2026-08415 Filed 4-29-26; 8:45 am]
BILLING CODE 7590-01-P